Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Paltusotine hydrochloride by Crinetics Pharmaceuticals for Carcinoid Syndrome (Malignant Carcinoid Syndrome): Likelihood of Approval
Paltusotine hydrochloride is under clinical development by Crinetics Pharmaceuticals and currently in Phase II for Carcinoid Syndrome (Malignant Carcinoid Syndrome)....
Paltusotine hydrochloride by Crinetics Pharmaceuticals for Acromegaly: Likelihood of Approval
Paltusotine hydrochloride is under clinical development by Crinetics Pharmaceuticals and currently in Pre-Registration for Acromegaly. According to GlobalData, Pre-Registration drugs...
CRN-04894 by Crinetics Pharmaceuticals for Congenital Adrenal Hyperplasia (Adrenogenital Syndrome): Likelihood of Approval
CRN-04894 is under clinical development by Crinetics Pharmaceuticals and currently in Phase II for Congenital Adrenal Hyperplasia (Adrenogenital Syndrome). According...
Paltusotine hydrochloride by Crinetics Pharmaceuticals for Carcinoid Syndrome (Malignant Carcinoid Syndrome): Likelihood of Approval
Paltusotine hydrochloride is under clinical development by Crinetics Pharmaceuticals and currently in Phase II for Carcinoid Syndrome (Malignant Carcinoid Syndrome)....